Simplify Logo

Full-Time

Executive Director

Clinical Regulatory Affairs

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

501-1,000 employees

Develops RNAi-based therapies for diseases

Hardware
Biotechnology
Healthcare

Compensation Overview

$280k - $320kAnnually

Expert

Pasadena, CA, USA + 1 more

Category
Public Health
Biology & Biotech
Required Skills
Word/Pages/Docs
PowerPoint/Keynote/Slides
Requirements
  • Minimum Bachelor of Science degree in a science-related field (with an advanced scientific degree preferred) and 10+ years of relevant experience in a regulated drug environment is required. The ideal candidate will also have management
  • In-depth understanding of regulations and guidelines governing all phases (pre-IND through post-approval) of drug development and working knowledge of US regulations and practices pertaining to the development, manufacture, testing and distribution of pharmaceutical products.
  • Good understanding of global clinical regulatory requirements for clinical trials particularly for key countries ex-US such as EU, Australia and
  • A demonstrated track record of successful regulatory filings e.g. IND/CTAs, NDA/BLA/MAAs is essential, with the ideal candidate having done several INDs and at least one registrational filing. Experience with bringing regulatory projects to commercialization is of value
  • Previous experience in leading a team to prepare for major regulatory agency interactions, such as FDA pre-NDA, EOP2 meetings, advisory committee meetings, and/or EU oral explanations/scientific advice
  • Highly proficient in the functionality of MS Word, Adobe Acrobat, and PowerPoint;
Responsibilities
  • In partnership with the Vice President, Regulatory Affairs, provide clinical regulatory expertise and leadership to ensure the Company builds credible and trustworthy relationships with health authorities based upon the submission of scientifically meritorious data and in conformance with quality standards
  • Interacts with FDA and other international regulatory agencies as needed, on a proactive, independent, and frequent basis; appropriately communicates company views to agencies
  • Supervise, manage, and collaborate with external service vendors, contractors and consultants as needed
  • Obtain, generate information and documents to be submitted to regulatory authorities; prepare effective planning timelines, and liaise with team contributors for the preparation of required regulatory documents and submissions
  • Provide regulatory subject matter expertise during the review of documentation, protocols and reports received; prepare additional written materials as needed
  • Review and interpret regulatory rules as they relate to Company products and procedures, clinical studies, testing or record-keeping and ensure they are communicated through Company policies and procedures; recommend and implement compliance strategies for existing and proposed products and activities
  • Take a leadership role in the development of regulatory functional infrastructure and business operations e.g. electronic documentation management systems/archiving, electronic publishing systems, documentation template development; serve as primary owner for Regulatory Affairs Standard Operating Procedures (SOPs)
  • Serve as backup to the Vice President, Regulatory Affairs on assigned core teams as needed; assist in submission risk assessment process
  • Handle various project budgets, as assigned
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure that the target genes are significantly reduced in activity. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. The goal of Arrowhead Pharmaceuticals is to provide new treatment options for patients suffering from genetic disorders, leveraging their expertise and partnerships to bring these therapies to market.

Company Stage

IPO

Total Funding

$899.9M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's recent $450 million funding round provides substantial financial resources to advance its drug pipeline and expand research initiatives.
  • Positive Phase 2 data for plozasiran and the initiation of an Expanded Access Program highlight the company's commitment to addressing unmet medical needs.
  • The company's diversified pipeline, including treatments for cystic fibrosis, hepatitis B, and myotonic dystrophy, offers multiple avenues for success.

What critics are saying

  • The high costs and lengthy timelines associated with drug development could strain Arrowhead's financial resources despite recent funding.
  • Regulatory hurdles and the potential for clinical trial failures pose significant risks to the company's drug approval process.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead Pharmaceuticals leverages RNA interference (RNAi) technology to target and silence disease-causing genes, setting it apart from traditional pharmaceutical approaches.
  • The company's proprietary TRiM platform enables tissue-specific targeting, enhancing the efficacy and safety of its therapies.
  • Strategic partnerships with major pharmaceutical companies like Takeda bolster Arrowhead's credibility and expand its research capabilities.